Fulgent Genetics Inc
NASDAQ:FLGT

Watchlist Manager
Fulgent Genetics Inc Logo
Fulgent Genetics Inc
NASDAQ:FLGT
Watchlist
Price: 27.86 USD 0.25% Market Closed
Market Cap: 861.2m USD

Fulgent Genetics Inc
Income to Minority Interest

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Fulgent Genetics Inc
Income to Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Fulgent Genetics Inc
NASDAQ:FLGT
Income to Minority Interest
$1.2m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Income to Minority Interest
-$57m
CAGR 3-Years
10%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
CVS Health Corp
NYSE:CVS
Income to Minority Interest
$41m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Income to Minority Interest
-$403m
CAGR 3-Years
-83%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Income to Minority Interest
-$1.2m
CAGR 3-Years
13%
CAGR 5-Years
-8%
CAGR 10-Years
0%
Guardant Health Inc
NASDAQ:GH
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Fulgent Genetics Inc
Glance View

Market Cap
859.6m USD
Industry
Health Care

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in Temple City, California and currently employs 645 full-time employees. The company went IPO on 2016-09-28. The firm develops a technology platform, which offers a test menu. The company performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. The company also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.

FLGT Intrinsic Value
18.12 USD
Overvaluation 35%
Intrinsic Value
Price

See Also

What is Fulgent Genetics Inc's Income to Minority Interest?
Income to Minority Interest
1.2m USD

Based on the financial report for Sep 30, 2025, Fulgent Genetics Inc's Income to Minority Interest amounts to 1.2m USD.

What is Fulgent Genetics Inc's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 3Y
-14%

Over the last year, the Income to Minority Interest growth was -83%. The average annual Income to Minority Interest growth rates for Fulgent Genetics Inc have been -14% over the past three years .

Back to Top